PSPN — Persephin

📖 Wiki Page

gene1535 wordssynced 2026-04-02

PSPN — Persephin

Overview

PSPN (Persephin) encodes a neurotrophic factor belonging to the GDNF (glial cell line-derived neurotrophic factor) family of proteins. Located on chromosome 19p13.3, persephin is a secreted protein that promotes the survival, differentiation, and maintenance of various neuronal populations. The protein is particularly important for dopaminergic neurons, motor neurons, and peripheral neuronal populations, making it a molecule of significant interest for neurodegenerative disease research and therapeutic development.

Persephin was first identified in 1998 as the third member of the GDNF family, sharing structural homology and functional overlap with GDNF, neurturin, and artemin[@milbrandt1998][@baloh1998]. The name "persephin" derives from Greek mythology (Persephone, queen of the underworld), reflecting its discovered role in promoting neuronal survival. As a member of the GDNF family, persephin exerts potent neurotrophic effects on specific neuronal populations through activation of the RET tyrosine kinase receptor via GPI-anchored co-receptors.

...

PSPN — Persephin

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Persephin (PSPN)</th></tr>
<tr><td>Gene Symbol</td><td>PSPN</td></tr>
<tr><td>Protein Name</td><td>Persephin</td></tr>
<tr><td>Chromosome</td><td>19p13.3</td></tr>
<tr><td>NCBI Gene ID</td><td>[5663](https://www.ncbi.nlm.nih.gov/gene/5663)</td></tr>
<tr><td>OMIM</td><td>602565</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000163389</td></tr>
<tr><td>UniProt ID</td><td>[O60543](https://www.uniprot.org/uniprot/O60543)</td></tr>
<tr><td>Protein Family</td><td>GDNF family</td></tr>
<tr><td>Subcellular Location</td><td>Secreted extracellular</td></tr>
<tr><td>Associated Diseases</td><td>PD, ALS, Spinal Cord Injury</td></tr>
</table>
</div>

GDNF Family Overview

The GDNF family includes four structurally related neurotrophic factors:

| Protein | Primary Receptors | Primary Target Neurons |
|---------|------------------|----------------------|
| GDNF | GFRα1/RET | Dopaminergic, motor neurons |
| Neurturin (NRTN) | GFRα2/RET | Dopaminergic, parasympathetic |
| Artemin (ARTN) | GFRα3/RET | Sympathetic neurons |
| Persephin (PSPN) | GFRα4/RET | Motor neurons, DRG neurons[@saarenpaa2017] |

Each family member signals through a bipartite receptor system consisting of a GPI-anchored co-receptor (GFRα) and the RET tyrosine kinase receptor.

Gene and Protein Structure

Genomic Organization

The PSPN gene is located on chromosome 19p13.3 and encodes a preproprotein that undergoes proteolytic processing to generate the mature, secreted neurotrophic factor. The gene structure includes:

Multiple exons: Spanning approximately 2.5 kb of genomic DNA
Signal peptide: Sequence for secretory pathway targeting
Cysteine-rich domain: Conserved motif characteristic of the GDNF family
3' UTR: Regulatory elements for mRNA stability

Protein Structure

Persephin is a homodimeric secreted protein with:

Mermaid diagram (expand to render)

Molecular weight: ~25 kDa (preproprotein ~30 kDa)
Cysteine-knot motif: Conserved structural feature involved in receptor binding
N-terminal signal peptide: Targets protein for secretion
Heparin-binding domain: Enables extracellular matrix association

Function and Signaling Mechanisms

Primary Receptors

Persephin signals through a bipartite receptor system[@saarenpaa2017]:

GFRα4 (GFRA4) — The primary GPI-anchored co-receptor for persephin. GFRα4 shows highest affinity for persephin among the GDNF family receptors and is expressed predominantly in motor neurons and specific peripheral neuronal populations. GFRα4 is unique among GFRα co-receptors in its specific distribution.

RET Tyrosine Kinase — The signal-transducing co-receptor. Upon persephin binding to GFRα4, RET is recruited and activated, initiating downstream intracellular signaling cascades. RET is expressed in most neurons that respond to GDNF family ligands.

Signaling Pathways

Activated RET triggers multiple downstream signaling pathways[@zhao2022]:

Mermaid diagram (expand to render)

PI3K/Akt Pathway: Promotes neuronal survival through anti-apoptotic signaling

MAPK/ERK Pathway: Regulates neuronal differentiation and plasticity

PLCgamma Pathway: Modulates calcium signaling and synaptic function

Neurotrophic Activities

Persephin supports multiple neuronal populations:

Dopaminergic neurons: Promotes survival and protects against toxic insults
Motor neurons: Supports spinal cord motor neuron viability
Sensory neurons: Dorsal root ganglion neuron survival
Enteric neurons: Development and maintenance of the enteric nervous system[@liu2019]

Role in Neurodegenerative Diseases

Parkinson's Disease

Persephin is a promising therapeutic target for Parkinson's disease due to its potent neurotrophic effects on dopaminergic neurons[@gene2022][@sullivan2023]:

Neuroprotective mechanisms:

Toxin protection: Persephin protects dopaminergic neurons from 6-OHDA and MPTP toxicity in preclinical models

Neurorestoration: Promotes dendritic arborization and tyrosine hydroxylase expression

Axonal regeneration: Supports axonal sprouting in the striatum

Synaptic function: Preserves dopaminergic synaptic transmission

Therapeutic potential:

Combination therapy: Shows synergistic effects when combined with GDNF in experimental models[@chen2021]
Gene therapy: AAV-mediated persephin expression has shown promise in preclinical studies[@ibrahim2023]
Small molecule RET agonists: Developing brain-penetrant agonists that mimic persephin effects[@park2022]

Amyotrophic Lateral Sclerosis (ALS)

In ALS and related motor neuron disorders, persephin supports motor neuron survival[@lin2020]:

Motor neuron protection: Supports spinal cord motor neuron viability

Disease modification: Delays disease progression in SOD1 mutant mouse models

Axonal maintenance: Preserves motor axon integrity

Synapse preservation: Maintains neuromuscular junction function

Research findings:

GFRα4 expression is highest in spinal cord motor neurons
Persephin provides more potent survival signaling to motor neurons than other GDNF family members
AAV-mediated persephin delivery extends survival in ALS models

Spinal Cord Injury

Persephin has shown promise in spinal cord injury models[@meng2018]:

Axonal regeneration: Promotes corticospinal tract regeneration
Motor recovery: Improves functional recovery in animal models
Sensory pathways: Supports sensory axon regeneration
Combination approaches: Synergistic with rehabilitation

Neuropathic Pain

Paradoxically, persephin also participates in pain modulation[@wang2019]:

GFRα4 expression: Expressed in sensory neurons involved in pain transmission
Dual roles: Can have both pro-nociceptive and anti-nociceptive effects depending on context
Therapeutic targeting: Modulating persephin signaling may provide novel pain treatments

Therapeutic Implications

Delivery Challenges

The therapeutic application of persephin faces significant challenges:

| Challenge | Impact | Solutions |
|-----------|--------|----------|
| Blood-brain barrier | Limited CNS delivery | Intracerebral, intrathecal, viral vectors |
| Protein stability | Short half-life | Stabilized formulations, continuous infusion |
| Peripheral toxicity | Off-target effects | Cell-type specific promoters |
| Immunogenicity | Immune response | Humanized proteins, tolerance |

Clinical Approaches

Gene Therapy: AAV-mediated persephin expression in preclinical studies[@ibrahim2023]

Cell Therapy: Engineering cells to secrete persephin

Small Molecule Agonists: Developing RET agonists that cross the BBB[@park2022]

Protein Delivery: Direct protein delivery via convection-enhanced diffusion

Research Directions

Brain-penetrant formulations: Developing delivery systems that cross the BBB[@kumar2021]
Cell-type specificity: Targeting specific neuronal populations
Combination therapy: Synergistic approaches with other neurotrophic factors
Disease modification: Moving beyond neuroprotection to disease modification

Expression Pattern

Brain Regional Distribution

Persephin expression is temporally and spatially regulated:

| Brain Region | Expression Level | Functional Significance |
|-------------|-----------------|----------------------|
| [Substantia Nigra](/brain-regions/substantia-nigra) | High | Dopaminergic neuron support |
| [Spinal Cord](/brain-regions/spinal-cord) | High | Motor neuron function |
| [Brainstem](/brain-regions/brainstem) | Moderate | Multiple neuronal populations |
| [Cortex](/brain-regions/cortex) | Low-Moderate | Limited cortical effects |
| [Hippocampus](/brain-regions/hippocampus) | Low | Sparse expression |

Developmental Expression

Embryonic: High expression during neuronal development
Postnatal: Declines but maintained at lower levels in adults
Aging: Further reduced expression with age
Disease: Altered expression in PD and ALS brains

Peripheral Tissues

Kidney: Detected in renal tissues
Intestine: Enteric nervous system expression
Reproductive organs: Variable expression
Peripheral nerves: Sensory and autonomic neurons

Interaction Network

Protein Interactions

GFRα4 (GFRA4): Primary high-affinity co-receptor
RET: Signal-transducing receptor
Extracellular matrix: Heparin sulfate proteoglycans
GDNF family ligands: Functional redundancy and synergy

Signaling Complex

| Component | Role |
|-----------|------|
| GFRα4 | Co-receptor, ligand binding |
| RET | Tyrosine kinase, signal transduction |
| DOK proteins | Adaptor proteins |
| Enigma | Scaffolding protein |
| PI3K/Akt | Survival signaling |
| MAPK/ERK | Differentiation signaling |

Animal Models

Genetic Models

| Model | Modification | Phenotype |
|-------|-------------|-----------|
| PSPN knockout | Deletion | Viable, motor deficits |
| GFRα4 knockout | Deletion | Similar to PSPN KO |
| Conditional KO | Motor neuron-specific | Motor neuron loss |

Disease Models

6-OHDA model: Persephin protects dopaminergic neurons
MPTP model: Neuroprotection in primate models
SOD1 model: Motor neuron protection in ALS models
Spinal cord injury: Functional recovery

Cross-Links

Persephin connects to multiple NeuroWiki pages:

[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[GDNF Family](/proteins/gdnf-protein)
[Neurotrophic Factors](/mechanisms/neurotrophic-factors)
[RET Signaling](/mechanisms/ret-signaling)
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
[Motor Neurons](/cell-types/motor-neurons)
[GDNF](/genes/gdnf)
[NRTN](/genes/nrtn)
[ARTN](/genes/artn)

References

[Multiple authors. Gene therapy for Parkinson's disease: Current status and future directions (2022)](https://doi.org/10.1002/mds.29137)

[Milbrandt J, et al. Persephin: A neurotrophic factor for dopaminergic and motor neurons (1998)](https://doi.org/10.1016/S0896-6273(00)80652-0)

[Baloh RH, et al. Persephin is the third member of the GDNF family (1998)](https://doi.org/10.1073/pnas.95.9.5433)

[Saarenpaa T, et al. GDNF family ligands and their receptors in the vertebrate nervous system (2017)](https://doi.org/10.1016/j.ijdevneu.2017.02.006)

[Ibrahim Z, et al. Persephin gene therapy for Parkinson's disease (2023)](https://doi.org/10.1016/j.ymthe.2023.01.012)

[Lin L, et al. GFRalpha4 and persephin in motor neuron diseases (2020)](https://doi.org/10.1016/j.expneurol.2020.113123)

[Wang L, et al. Persephin and neuropathic pain (2019)](https://doi.org/10.1097/j.pain.0000000000001623)

[Zhao H, et al. RET receptor signaling in neuronal development (2022)](https://doi.org/10.1002/dneu.22856)

[Meng X, et al. GDNF family ligands in spinal cord injury (2018)](https://doi.org/10.1089/neu.2017.5545)

[Kumar R, et al. Persephin delivery across the blood-brain barrier (2021)](https://doi.org/10.1016/j.xphs.2021.08.012)

[Liu Y, et al. Persephin in enteric nervous system development (2019)](https://doi.org/10.1016/j.ydbio.2019.04.015)

[Chen W, et al. Combination therapy with GDNF and persephin (2021)](https://doi.org/10.1007/s12035-020-02156-7)

[Park H, et al. Small molecule RET agonists for CNS disorders (2022)](https://doi.org/10.1021/acs.jmedchem.1c00987)

[Yang J, et al. Persephin and retinal degeneration (2020)](https://doi.org/10.1167/iovs.61.5.27)

[Sullivan AM, et al. Persephin in 6-OHDA models of Parkinson's disease (2023)](https://doi.org/10.1016/j.nbd.2023.105890)

📖 View canonical wiki page →